Anti-HLA-A2-peptide (KVLEHVVRV
) Complex (H2aM31345N), 抗HLA-A2-peptide (KVLEHVVRV)复合物抗体 (H2aM31345N)- ￥1668
- abinScience
- China
- HM832373
- 2026年03月03日
- ELISA, SPR
- Human
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Human
- 亚型：
IgG, kappa
- 形态：
Liquid
- 保存条件：
0.01M PBS pH 7.4
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Human
- 保质期：
1 year
- 抗原来源：
Human
- 目录编号：
HM832373
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Human
- 应用范围：
ELISA, SPR
- 浓度：
1mg/mL
- 靶点：
HLAA, Human leukocyte antigen A, HLA class I histocompatibility antigen, A alpha chain, HLA-A, Melanoma-associated antigen 4, Cancer/testis antigen 1.4, CT1.4, MAGE-4 antigen, MAGE-41 antigen, MAGE-X2 antigen, MAGEA4, MAGE4
- 抗体英文名：
Anti-HLA-A2-peptide (KVLEHVVRV) Complex (H2aM31345N)
- 抗体名：
Anti-HLA-A2-peptide (KVLEHVVRV) Complex (H2aM31345N)
- 规格：
100ul
| Product name | Anti-HLA-A2-peptide (KVLEHVVRV) Complex (H2aM31345N) |
|---|---|
| Catalog No. | HM832373 |
| Host species | Human |
| Species reactivity | Human |
| Immunogen | / |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 |
| Purity | >95% as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG, kappa |
| Applications | ELISA, SPR |
| Target | HLAA, Human leukocyte antigen A, HLA class I histocompatibility antigen, A alpha chain, HLA-A, Melanoma-associated antigen 4, Cancer/testis antigen 1.4, CT1.4, MAGE-4 antigen, MAGE-41 antigen, MAGE-X2 antigen, MAGEA4, MAGE4 |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | Please contact with the lab for this information. |
| Expression system | / |
| Accession | P43358, P04439, P43358 |
| Alternative Names | / |
| Clone ID | H2aM31345N |
| Species | / |
| Product Usage Information | / |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product research and development.
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Retroviral Transfer of T-Cell Receptor Genes into Human Peripheral Blood Lymphocytes
melanoma tumors (1 ,2 ), making it an excellent potential target for therapeutic strategies utilizing TCR gene transfer. A single HLA-A2-restricted peptide epitope has been identified in the MART-1 protein (amino acids 27-35: MART-1(27 _35 )). HLA-A2
Assessing Antigen-Specific CD8+ CTL Responses in Humans
recognized by NP-specific CTL in a major histocompatability complex (MHC) class I restricted manner (5 ,6 ). Bjorkman et al. (6 ,7 ) subsequently resolved the structure of the human class I molecule HLA-A2 by x-ray crystallography and provided evidence
Peptide/HLA Class I Complex and Significantly Impedes Tumor Growth In Vivo Using Breast Cancer Models2. An anti–PR1/HLA-A2 T-cell receptor–like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells
技术资料暂无技术资料 索取技术资料
